Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04294095 · ClinicalTrials.gov registry record · NA
My Baby My Move A Community Wellness Intervention
A NA study of Gestational Weight Gain, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
- 1
- Study location
NCT04294095: Completed NA study of Gestational Weight Gain, sponsored by University of Colorado, Denver.
NCT04294095 is a NA study of Gestational Weight Gain that has completed, run by University of Colorado, Denver. The registered enrollment target is 68 participants, below the 484-participant average among 7 other Gestational Weight Gain trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04294095, a NA study of Gestational Weight Gain, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
- 1
- Study location
Study Summary
My Baby, My Move+ (2019-2021) is a peer-led wellness intervention which aims to reduce excessive gestational weight gain (EGWG) by targeting prenatal physical activity, mood, and sleep quality. Up to 50% of pregnant women in the U.S. gain weight in excess of the Institute of Medicine guidelines. EGWG leads to poor maternal and child outcomes. It also sets the stage for long-term overweight/obesity for both mother and child. The MBMM+ intervention is an example of a theoretically-based prenatal physical activity intervention that targets these outcomes. Up to 100 pregnant women (50 intervention arm, 50 control arm) will be recruited from the University of Colorado Clinics. Women in the intervention arm will participate in the 12-week MBMM+ intervention. Leiferman and her team propose to develop and test the feasibility and sustainability of the MBMM+ intervention to instill good healthy habits (e.g., prenatal physical activity, good sleep hygiene, stress management) during and beyond pregnancy. Findings from this study will be used to inform a future, large randomized trial.
Primary Outcome
Average weight
Conditions Studied
Interventions
- OTHER Control
- OTHER My Baby My Move +
Study Locations (1)
Colorado
- University of Colorado Anschutz Campus - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2022-01-01 |
| Phase | NA |
What the finished NCT04294095 record still lists
NCT04294095 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 484-participant average among 7 other Gestational Weight Gain trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Gestational Weight Gain appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT04294095 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT04294095 about?
NCT04294095 is a clinical study titled "My Baby My Move A Community Wellness Intervention". My Baby, My Move+ (2019-2021) is a peer-led wellness intervention which aims to reduce excessive gestational weight gain (EGWG) by targeting prenatal physical activity, mood, and sleep quality. Up to 50% of pregnant women in the U.S. gain weight in excess of the Institute of Medicine guidelines. EGW...
What is the current status of trial NCT04294095?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2020-09-01. Estimated completion is 2022-01-01.
What conditions does trial NCT04294095 study?
This clinical trial studies the following conditions: Gestational Weight Gain.
What interventions are being tested in trial NCT04294095?
The interventions under investigation include: Control (OTHER), My Baby My Move + (OTHER).
Who is sponsoring clinical trial NCT04294095?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04294095 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Weight Gain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Teen Mom Study Feasibility Trial
RECRUITING · NA
-
Delivering HOPE (Helping Women Optimize Prenatal Equity)
RECRUITING · NA
-
Healthy Mom Zone Gestational Weight Gain Management Intervention 2.0
RECRUITING · NA
-
Cessation of Dual Use of Cigarettes and E-cigarettes During Pregnancy
RECRUITING · NA
-
Preventing Excessive Gestational Weight Gain Via Short Mobile Messages in WIC
COMPLETED · NA
-
Meals for Moms: Medically-Tailored Meals for Women Who Had Gestational Diabetes
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI